These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 32207033)

  • 1. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease.
    Desai M; Knight K; Gray JM; Nguyen V; Boone J; Sorrentino D
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1099-1105. PubMed ID: 32516177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
    Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Lee MR; Kim ES
    Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
    Dalal RS; Allegretti JR
    Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.
    Horton HA; Dezfoli S; Berel D; Hirsch J; Ippoliti A; McGovern D; Kaur M; Shih D; Dubinsky M; Targan SR; Fleshner P; Vasiliauskas EA; Grein J; Murthy R; Melmed GY
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5054-9. PubMed ID: 24913174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
    Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
    Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    Lei DK; Ollech JE; Andersen M; Weisshof R; Zmeter N; Sossenheimer P; Rubin DT
    Am J Gastroenterol; 2019 Dec; 114(12):1904-1908. PubMed ID: 31714359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.
    Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Chandrakumar A; Zohni H; El-Matary W
    Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization and antibiotic resistance of Clostridioides difficile in patients with inflammatory bowel disease from two hospitals in China.
    Lv T; Zheng L; Wu T; Shen P; Chen Y
    J Glob Antimicrob Resist; 2022 Sep; 30():252-258. PubMed ID: 35764214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
    Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
    Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic risk factors for Clostridium difficile infection in ulcerative colitis.
    Ananthakrishnan AN; Oxford EC; Nguyen DD; Sauk J; Yajnik V; Xavier RJ
    Aliment Pharmacol Ther; 2013 Sep; 38(5):522-30. PubMed ID: 23848254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.